The treatment market is changing with a growing number of disease subtypes and therefore newer targeted therapies and more complex clinical trials. This involves challenges in recruiting patients, operational and design issues with global studies, new pharmacogenomics approaches and questions surrounding biomarkers. The search for novel treatments encompasses a range of design and implementation challenges. To meet these challenges iBrain offer service that allows you to obtain advice, Assistance in the formulation, Testing and scientific interpretation of the data related to novel therapy.

Collaboration and communication are key to a successful research and development programme and are fundamental principles within iBrain. Expert scientists will work in partnership with you on the design of individual protocols or entire research programmes to facilitate the development of your therapy. Ongoing data feedback maximizes the flow of information, allowing efficient progression through the research programme. The flexibility of the preclinical services provided by iBrain allows the research programme to be updated as necessary ensuring the development process is not hindered. The overall process will be managed by a dedicated Project coordinator.